397 related articles for article (PubMed ID: 33786894)
1. Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias.
Shafi S; Singh A; Ibrahim AM; Alhajri N; Abu Izneid T; Pottoo FH
Eur J Neurosci; 2021 May; 53(10):3294-3310. PubMed ID: 33786894
[TBL] [Abstract][Full Text] [Related]
2. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease.
Rayaprolu S; Mullen B; Baker M; Lynch T; Finger E; Seeley WW; Hatanpaa KJ; Lomen-Hoerth C; Kertesz A; Bigio EH; Lippa C; Josephs KA; Knopman DS; White CL; Caselli R; Mackenzie IR; Miller BL; Boczarska-Jedynak M; Opala G; Krygowska-Wajs A; Barcikowska M; Younkin SG; Petersen RC; Ertekin-Taner N; Uitti RJ; Meschia JF; Boylan KB; Boeve BF; Graff-Radford NR; Wszolek ZK; Dickson DW; Rademakers R; Ross OA
Mol Neurodegener; 2013 Jun; 8():19. PubMed ID: 23800361
[TBL] [Abstract][Full Text] [Related]
3. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
Zhou SL; Tan CC; Hou XH; Cao XP; Tan L; Yu JT
J Alzheimers Dis; 2019; 68(3):1171-1184. PubMed ID: 30883352
[TBL] [Abstract][Full Text] [Related]
4. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
Kleinberger G; Yamanishi Y; Suárez-Calvet M; Czirr E; Lohmann E; Cuyvers E; Struyfs H; Pettkus N; Wenninger-Weinzierl A; Mazaheri F; Tahirovic S; Lleó A; Alcolea D; Fortea J; Willem M; Lammich S; Molinuevo JL; Sánchez-Valle R; Antonell A; Ramirez A; Heneka MT; Sleegers K; van der Zee J; Martin JJ; Engelborghs S; Demirtas-Tatlidede A; Zetterberg H; Van Broeckhoven C; Gurvit H; Wyss-Coray T; Hardy J; Colonna M; Haass C
Sci Transl Med; 2014 Jul; 6(243):243ra86. PubMed ID: 24990881
[TBL] [Abstract][Full Text] [Related]
5. TREM2 in Neurodegenerative Diseases.
Jay TR; von Saucken VE; Landreth GE
Mol Neurodegener; 2017 Aug; 12(1):56. PubMed ID: 28768545
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous TREM2 mutations in frontotemporal dementia.
Borroni B; Ferrari F; Galimberti D; Nacmias B; Barone C; Bagnoli S; Fenoglio C; Piaceri I; Archetti S; Bonvicini C; Gennarelli M; Turla M; Scarpini E; Sorbi S; Padovani A
Neurobiol Aging; 2014 Apr; 35(4):934.e7-10. PubMed ID: 24139279
[TBL] [Abstract][Full Text] [Related]
7. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
[TBL] [Abstract][Full Text] [Related]
8. TREM2, Microglia, and Neurodegenerative Diseases.
Yeh FL; Hansen DV; Sheng M
Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
[TBL] [Abstract][Full Text] [Related]
9. Soluble TREM2: Innocent bystander or active player in neurological diseases?
Filipello F; Goldsbury C; You SF; Locca A; Karch CM; Piccio L
Neurobiol Dis; 2022 Apr; 165():105630. PubMed ID: 35041990
[TBL] [Abstract][Full Text] [Related]
10. The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders.
Carmona S; Zahs K; Wu E; Dakin K; Bras J; Guerreiro R
Lancet Neurol; 2018 Aug; 17(8):721-730. PubMed ID: 30033062
[TBL] [Abstract][Full Text] [Related]
11. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease.
Giraldo M; Lopera F; Siniard AL; Corneveaux JJ; Schrauwen I; Carvajal J; Muñoz C; Ramirez-Restrepo M; Gaiteri C; Myers AJ; Caselli RJ; Kosik KS; Reiman EM; Huentelman MJ
Neurobiol Aging; 2013 Aug; 34(8):2077.e11-8. PubMed ID: 23582655
[TBL] [Abstract][Full Text] [Related]
12. Frontotemporal dementia presentation in patients with heterozygous p.H157Y variant of
Ogonowski N; Santamaria-Garcia H; Baez S; Lopez A; Laserna A; Garcia-Cifuentes E; Ayala-Ramirez P; Zarante I; Suarez-Obando F; Reyes P; Kauffman M; Cochran N; Schulte M; Sirkis DW; Spina S; Yokoyama JS; Miller BL; Kosik KS; Matallana D; Ibáñez A
J Med Genet; 2023 Sep; 60(9):894-904. PubMed ID: 36813542
[TBL] [Abstract][Full Text] [Related]
13. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
Lue LF; Schmitz C; Walker DG
Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes.
Thelen M; Razquin C; Hernández I; Gorostidi A; Sánchez-Valle R; Ortega-Cubero S; Wolfsgruber S; Drichel D; Fliessbach K; Duenkel T; Damian M; Heilmann S; Slotosch A; Lennarz M; Seijo-Martínez M; Rene R; Kornhuber J; Peters O; Luckhaus C; Jahn H; Hüll M; Rüther E; Wiltfang J; Lorenzo E; Gascon J; Lleó A; Lladó A; Campdelacreu J; Moreno F; Ahmadzadehfar H; ; Fortea J; Indakoetxea B; Heneka MT; Wetter A; Pastor MA; Riverol M; Becker T; Frölich L; Tárraga L; Boada M; Wagner M; Jessen F; Maier W; Clarimón J; López de Munain A; Ruiz A; Pastor P; Ramirez A
Neurobiol Aging; 2014 Nov; 35(11):2657.e13-2657.e19. PubMed ID: 25042114
[TBL] [Abstract][Full Text] [Related]
15. Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype.
Li H; Knight WC; Yang P; Guo Y; Perlmutter JS; Morris JC; Bateman RJ; Benzinger TLS; Xu J
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842621
[TBL] [Abstract][Full Text] [Related]
16. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models.
Jay TR; Miller CM; Cheng PJ; Graham LC; Bemiller S; Broihier ML; Xu G; Margevicius D; Karlo JC; Sousa GL; Cotleur AC; Butovsky O; Bekris L; Staugaitis SM; Leverenz JB; Pimplikar SW; Landreth GE; Howell GR; Ransohoff RM; Lamb BT
J Exp Med; 2015 Mar; 212(3):287-95. PubMed ID: 25732305
[TBL] [Abstract][Full Text] [Related]
17. The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.
Kleinberger G; Brendel M; Mracsko E; Wefers B; Groeneweg L; Xiang X; Focke C; Deußing M; Suárez-Calvet M; Mazaheri F; Parhizkar S; Pettkus N; Wurst W; Feederle R; Bartenstein P; Mueggler T; Arzberger T; Knuesel I; Rominger A; Haass C
EMBO J; 2017 Jul; 36(13):1837-1853. PubMed ID: 28559417
[TBL] [Abstract][Full Text] [Related]
18. Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration.
Fenoglio C; Galimberti D; Piccio L; Scalabrini D; Panina P; Buonsanti C; Venturelli E; Lovati C; Forloni G; Mariani C; Bresolin N; Scarpini E
Neurosci Lett; 2007 Jan; 411(2):133-7. PubMed ID: 17088018
[TBL] [Abstract][Full Text] [Related]
19. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J;
Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969
[TBL] [Abstract][Full Text] [Related]
20. The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.
Wolfe CM; Fitz NF; Nam KN; Lefterov I; Koldamova R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
